摘要
目的 探讨经皮肝穿胆道造影结合其它影像检查对胆管癌的诊断价值 ,并分析胆管癌胆道支架和药盒置入双介入疗法的效果。方法 34例病人术前均行CT及MRCP诊断考虑胆管癌 ,术中经胆道造影及胆汁CEA检查、脱落细胞检查 ,明确诊断并行胆道支架术和药盒置入术。化疗方案如下 :顺铂 2 0～ 4 0mg、丝裂霉素 6～ 16mg、表阿霉素2 0～ 4 0mg、5 Fu 2 5 0mg。给药间隔为前 3个月 ,每月 1次 ,后续为每 3个月 1次。结果 胆道造影与CT、MRI诊断符合率为 10 0 %。 34例病人生存率在 1,6 ,12 ,2 4个月分别为 94 1% (32 34) ,85 3% (2 9 34) ,6 1 8% (2 1 34) ,35 3% (12 34)。结论 胆道支架结合药盒置入对恶性胆道梗阻具有很高的疗效。
Objective By review of 34 cases of biliary tree cancer which have been diagnosed by percutaneous transheptic cholangiography(PTC), computed tomography(CT), magnetic resonance cholangiography(MRCP), and cured by percutaneous biliary stents implantation combined with chemotheraphy infusion through port catherter system(PCS), to evaluate the methods of “double intervention”.Methods All 34 cases diagnosed by CT and MRCP biliary tree cancer, and procedure percutaneous biliary stents implantation combined with implantalbe perfusion catherter. Combined chemotherapy:Cisplatin 20～40 mg, Mitomycin 6～16 mg, Epirubicin 20～40 mg, 5-Fu 250 mg. The medicine infusion was treated once every month at the first 3 month, and every 3 month at later.Results The result of CT, MRCP is fit to TPC. Survival rate after operation at 1, 6, 12 and 24 months in 94.1%, 85.3%, 61.8% and 35.3%. 12 cases(35.3%) survived over 2 year, that means this “double interventional method” is benefit to patient's life. Only 3 of 22 dead cases(13.6%) was found regained.Conclusion It also seemed the regained constriction is not the main factor for the earlier death cases.
出处
《中国实验诊断学》
2004年第3期248-250,共3页
Chinese Journal of Laboratory Diagnosis
关键词
胆管癌
支架
药盒
放射学价入
biliary tree cancer
stent
port catherter system
radiology/interventional
